Capricor Therapeutics (CAPR) News Today

$3.17

+0.21 (+7.09%)

(As of 12/4/2023 ET)

Today's Range: $2.99
▼
$3.25
50-Day Range: $2.71
▼
$5.90
52-Week Range: $2.68
▼
$8.22

Volume: 282,743 shs
Average Volume: 138,192 shs
Market Capitalization: $97.60 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $40.00

Source

Source	Headline
	Capricor Therapeutics (NASDAQ:CAPR) Stock Passes Below Two Hundred Day Moving Average of $4.58 americanbankingnews.com - November 25 at 3:22 AM
	Is Capricor Therapeutics (NASDAQ:CAPR) In A Good Position To Invest In Growth? finance.yahoo.com - November 16 at 4:08 PM
	Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 16 at 8:43 AM
	Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - November 14 at 7:36 PM
	What Wall Street expects from Capricor Therapeutics's earnings markets.businessinsider.com - November 13 at 7:12 PM
	Capricor Therapeutics Q3 2023 Earnings Preview msn.com - November 13 at 7:12 PM
	Preview: Capricor Therapeutics's Earnings benzinga.com - November 13 at 2:12 PM
	Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14 finance.yahoo.com - November 7 at 1:03 PM
	Smart for Life, Inc. (SMFL) May Report Negative Earnings: Know the Trend Ahead of Q3 Release finance.yahoo.com - November 6 at 3:26 PM
	Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline finance.yahoo.com - November 2 at 12:31 PM
	Capricor Therapeutics (CAPR) Price Target Increased by 16.42% to 26.52 msn.com - November 1 at 7:55 AM
	Chief Financial Officer at Capricor Therapeutics Exercises Options Worth $6K benzinga.com - October 25 at 4:00 PM
	After Plunging -52.01% in 4 Weeks, Here's Why the Trend Might Reverse for Capricor (CAPR) finance.yahoo.com - October 25 at 4:00 PM
	After Plunging -50.99% in 4 Weeks, Here's Why the Trend Might Reverse for Capricor (CAPR) finance.yahoo.com - October 24 at 1:29 PM
	Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments of CAP-1002 Program finance.yahoo.com - October 19 at 7:17 PM
	Capricor Therapeutics Announces Late-Breaking Presentations at 28th Annual Congress of the World Muscle Society finance.yahoo.com - October 10 at 1:31 PM
	HC Wainwright & Co. Maintains Capricor Therapeutics (CAPR) Buy Recommendation msn.com - October 6 at 8:53 AM
	Capricor Therapeutics (CAPR) Price Target Increased by 48.89% to 22.78 msn.com - October 6 at 8:53 AM
	Cell Therapy Market to grow by USD 31.04 billion from 2022 to 2027 \| Proven effectiveness of CAR T-cell therapy boosts the market - Technavio benzinga.com - October 4 at 7:01 PM
	Curis, Corcept Therapeutics among healthcare movers msn.com - September 30 at 10:34 AM
	Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings benzinga.com - September 29 at 12:44 PM
	Capricor Therapeutics: FDA Feedback Confirms CAP-1002's Path Towards BLA markets.businessinsider.com - September 29 at 12:44 PM
	Capricor Therapeutics Shares Drop 41% After Direct Offering Prices marketwatch.com - September 29 at 12:44 PM
	Capricor Therapeutics Announces Positive Type-B Meeting with the FDA to Discuss Pathway to BLA for CAP-1002 in Duchenne Muscular Dystrophy finance.yahoo.com - September 29 at 7:43 AM
	Capricor Therapeutics Appoints Michael Kelliher to Board of Directors finance.yahoo.com - September 6 at 4:59 PM
	Capricor Therapeutics, Inc. (NASDAQ:CAPR): Is Breakeven Near? finance.yahoo.com - August 28 at 7:52 AM
	Capricor Therapeutics (NASDAQ:CAPR) Research Coverage Started at StockNews.com marketbeat.com - August 17 at 4:10 AM
	HC Wainwright & Co. Reiterates Capricor Therapeutics (CAPR) Buy Recommendation msn.com - August 15 at 9:49 PM
	H.C. Wainwright Sticks to Its Buy Rating for Capricor Therapeutics (CAPR) markets.businessinsider.com - August 15 at 9:26 AM
	Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q2 2023 Earnings Call Transcript finance.yahoo.com - August 8 at 6:02 PM
	Capricor Therapeutics GAAP EPS of -$0.29 beats by $0.06, revenue of $3.92M beats by $2.32M msn.com - August 7 at 4:51 PM
	Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - August 7 at 4:51 PM
	Capricor Therapeutics (CAPR) Set to Announce Quarterly Earnings on Monday marketbeat.com - August 4 at 9:42 AM
	Capricor Therapeutics to Present Second Quarter 2023 Financial Results and Recent Corporate Update on August 7 finance.yahoo.com - August 3 at 7:13 AM
	Capricor Therapeutics Announces Appointment of Philip J. Gotwals, Ph.D. to its Board of Directors finance.yahoo.com - July 24 at 8:58 AM
	Capricor Therapeutics Announces Appointment of Paul Auwaerter, M.D. to its Board of Directors finance.yahoo.com - July 13 at 10:33 AM
	The past five years for Capricor Therapeutics (NASDAQ:CAPR) investors has not been profitable finance.yahoo.com - July 6 at 2:12 PM
	Capricor Reports Positive Results on Two-Year Duchenne Study marketwatch.com - June 30 at 1:12 PM
	Capricor Therapeutics Announces Positive 24-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy finance.yahoo.com - June 30 at 1:12 PM
	Capricor Therapeutics to Present 24-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy finance.yahoo.com - June 13 at 5:12 PM
	Capricor Therapeutics Announces Follow-up Type-B Clinical Meeting with the FDA for CAP-1002 for the Treatment of Duchenne Muscular Dystrophy benzinga.com - June 7 at 1:26 PM
	Capricor Therapeutics Gets Type-B Meeting With FDA for CAP-1002 marketwatch.com - June 7 at 1:26 PM
	Cell Therapy and Acellular Therapy Market Growth Opportunities Till 2030 marketwatch.com - May 17 at 8:37 AM
	Capricor Therapeutics, Inc. (NASDAQ:CAPR) Shares Could Be 27% Above Their Intrinsic Value Estimate finance.yahoo.com - May 13 at 2:30 PM
	Recap: Capricor Therapeutics Q1 Earnings msn.com - May 11 at 7:51 PM
	Capricor Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - May 11 at 7:51 PM
	Dilated Cardiomyopathy Therapeutics Market Growth 2023-2030 marketwatch.com - May 11 at 9:49 AM
	Capricor Therapeutics to Present First Quarter 2023 Financial Results and Recent Corporate Update on May 11 finance.yahoo.com - May 4 at 9:52 AM
	Capricor Announces Peer-Reviewed Publication Demonstrating the Therapeutic Potential of Exosome-Based Multivalent Vaccine Developed from its StealthX™ Platform finance.yahoo.com - April 27 at 10:34 AM
	2023-2030 Restrictive Cardiomyopathy Treatment Market Size with [85 Pages] includes Industry Chain Analysis \| New Report by Absolute Reports marketwatch.com - April 19 at 9:21 PM

Get Capricor Therapeutics News Delivered to You Automatically

CAPR Media Mentions By Week

CAPR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CAPR
News Sentiment
▼
0.44

0.70
▲
Average
Medical
News Sentiment

CAPR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CAPR Articles
This Week
▼
1

1
▲
CAPR Articles
Average Week

Get Capricor Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:CAPR) was last updated on 12/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Capricor Therapeutics (CAPR) News Today

CAPR Media Mentions By Week

CAPR Media Sentiment

CAPR News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info